These data suggest that enhanced MAPK signaling can play a role in additional functional benefits of NRG1-AdMSCs compared to AdMSCs, whereas AKT signaling can serve to promote AdMSCs-mediated functional improvements after ischemic stroke. Here, NRG1 is linked to ischemic stroke.